$SNPS

OpenAI and Synopsys Announce GPT-Synopsys: Frontier Intelligence to Revolutionize Chip Design

Synopsys (SNPS) and OpenAI announced a multi-year partnership to develop GPT-Synopsys, a specialized AI model for chip design. The collaboration combines OpenAI's AI capabilities with Synopsys' EDA tools. The agreement includes revenue sharing and joint go-to-market initiatives. Synopsys will license its EDA tools to OpenAI for this project. The partnership aims to accelerate semiconductor innovation and improve chip design processes.

Original reporting
Published Sep 30, 2026, 6:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 30, 2026, 6:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
OpenAI and Synopsys Announce GPT-Synopsys: Frontier Intelligence to Revolutionize Chip Design — source image
Decision brief

The 30-second read

$SNPSBullishLow
01

Why it matters

The deal could create a new product line, expand Synopsys' addressable market, and position the company as a leader in AI‑enhanced semiconductor design.

02

Market read

First disclosure of a strategic AI partnership that may drive future revenue growth for Synopsys and influence the semiconductor design sector.

03

What to watch

Potential regulatory scrutiny of AI models in critical chip design workflows and competition from other AI‑EDA collaborations.

Relevance 7/10Novelty 7/10Timing: today

Background

Synopsys (NASDAQ: SNPS) is a leading provider of electronic design automation (EDA) tools. OpenAI is a leading AI research organization. Their collaboration aims to embed AI directly into chip design processes.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys announced a multi-year strategic partnership with OpenAI to develop GPT-Synopsys, a specialized AI model for chip design, marking the first public disclosure of this collaboration.

Expected impact

likely upward pressure as investors price in potential revenue growth and market share gains from AI integration

Evidence & confidence

First‑time disclosure of a high‑profile AI partnership; no prior market pricing of this specific deal.

Market effects

Could spur broader AI adoption in semiconductor EDA tools, benefiting peers in the chip design software space.

U.S. tech sector may see modest uplift; no immediate regional effect.

Highlights growing convergence of AI and semiconductor design globally.

Counterpoint

The partnership may face integration challenges and limited near‑term revenue, keeping the stock neutral.

Key entities

  • Synopsys

    NASDAQ-listed EDA tool provider.

  • OpenAI

    AI research and deployment organization.

Related articles

$SNPSMed

Synopsys Details Growth Strategy and Long-term Financial Model at 2026 Investor Day

Synopsys (NASDAQ: SNPS) updated its long-term growth targets at its 2026 Investor Day, expecting fiscal year 2027 revenue of $11.15 billion (15% YoY growth). The company plans to return up to 50% of free cash flow to shareholders via share repurchases, aiming to buy back $1 billion in shares. Synopsys highlighted AI-driven demand and partnerships, including a deal with Amazon and a collaboration with OpenAI for AI-powered chip design.

$SNPSHighAI 8/10

Synopsys And OpenAI Team Up On GPT-Synopsys

Synopsys and OpenAI partnered to create GPT-Synopsys, sharing revenue based on AI-driven chip design improvements. Synopsys raised its fiscal 2027 revenue growth outlook to 15%, exceeding analyst estimates. The deal introduces value-based pricing but maintains traditional verification steps, reducing AI replacement risk.

$SNPSMed

Synopsys (SNPS) Partners with OpenAI to Integrate AI into Semico

Synopsys (SNPS) announced a multi-year partnership with OpenAI to develop GPT-Synopsys, an AI-driven model for semiconductor design. The collaboration aims to optimize workflows and includes a revenue-sharing agreement. SNPS is trading at $432, 34.4% below its GF Value™ of $658.56, with a GF Score™ of 91. Insider activity shows $48.2M in sales over the past year.

$SNPSHighAI 9/10

Synopsys stock analysis: what does today’s news tell investors?

Synopsys Inc (SNPS) stock rose 4.97% to $435.70 after announcing a $1B+ multi-year deal with Amazon.com (AMZN) for silicon IP licensing. The deal introduces a new license-plus-royalty model. Additionally, Synopsys partnered with OpenAI to develop GPT-Synopsys for semiconductor design. CEO Sassine Ghazi raised FY2027 revenue growth guidance to 15%, above analyst consensus of 11.19%.

$SNPSHigh

Synopsys shares jump on GPT-Synopsys chip design deal with OpenAI

Synopsys (SNPS) and OpenAI announced a multi-year partnership to develop GPT-Synopsys, an AI model for chip design. Synopsys shares rose 4.19% to $435.50 on the news, part of a 9.94% climb over 20 trading sessions. The deal involves revenue sharing and software licensing, but financial terms were not disclosed. Synopsys reported quarterly revenue of $2.48bn and net income of $545.8m for the quarter ended 31 July 2026.